Sharon Laboratories Announces Agreement to Acquire RES Pharma Industriale
Global leader in innovative personal care preservative solutions expands technology and ingredient portfolio, enhancing its ability to partner with leading consumer products companies
Ashdod, Israel – 1 March 2022 – Sharon Laboratories, Ltd. (Ashdod, Israel), a leading global innovator and manufacturer of preservative solutions for cosmetics and personal care markets, announced today that it has signed a definitive agreement to acquire specialty ingredients producer RES Pharma Industriale based in Trezzo sull’Adda, Italy (RPI). The acquisition of RPI, whose technology, R&D, manufacturing, commercial development and customer service capabilities will be integrated into the Personal Care business of Sharon Laboratories, is expected to close in March of 2022.
Established in 2004, RPI is a chemical company specialized in research, innovation and the production of personal care ingredients. RPI has a global customer base for green functional ingredients, such as texturizers, emulsifiers, surfactants and solubilizers – as well as smart solutions for specific segments such as wet wipes. These ingredients are used in virtually every segment of the personal care industry, including cosmetics, haircare, skincare, sun care and more.
According to Naama Eylon, General Manager of Sharon Laboratories, a broader, more diverse portfolio of cosmetic ingredients beyond preservation will further strengthen Sharon’s global reach and position, as a leading specialty solution provider to the cosmetics industry.
“Sharon and RES Pharma are a perfect match, strategically and culturally. We are excited to integrate technologies and further develop the company’s product segments,” she said. “The unique technical expertise each company brings will position us as a key partner for personal care and specifically for the wet-wipes industry. The combination of Sharon preservation and RES Pharma texturizing and concept formulation expertise will allow us to provide our customers with advanced support for developing sustainable, smart formulations,” she added.
Mr. Agostino Facchini, Founder and President of RES Pharma Industriale is optimistic about the potential for the new organization. “RES Pharma Industriale is a well-established company with strong roots, which has continued to grow and develop over the years. I’m convinced Sharon Laboratories is the best partner to take RES Pharma Industriale into the next stage. This is more than a transaction, I see it as two families coming together,” he said.
About Sharon Laboratories
Headquartered in Ashdod, Israel, Sharon Laboratories offers a wide range of innovative and patented preservative solutions for personal care products, following a focused, scientific approach to addressing the industry’s most challenging preservation needs. Established in 1977 by Dr. Danny Sommerfeld, the company employs more than 100 people worldwide, focusing on scientific research, development and marketing of advanced preservative solutions. Sharon Laboratories has a global presence. In 2019 it established its first European operation in Italy and expanded to North America when Sharon Labs USA started operating in 2021. The company markets a broad line of green preservative solutions under its SharoSENSE™, Sharomix™, Sharon™ Biomix, SharoSUN™, Sharowipes™ brand names. Sharon Laboratories is owned by Tene Investment Funds (Tel Aviv), an Israeli private equity growth fund focused on the industrial and technology sectors, as the majority holding, as well as Mr. Assaf Burstein, Sharon’s Chairman.
About RES Pharma Industriale
RES Pharma Industriale is a chemical company specialized in the Research, development and production of cosmetic ingredients for personal care, skincare, haircare and wet wipes segments. Founded in 2004, in recent years, RPI has consolidated its reputation as a manufacturer of innovative and nature-oriented cosmetic specialties. A green philosophy drives each innovation choice and strategy regarding both product development (Ecocert, Cosmos, Nature approved products) and a commitment to sustainability (RSPO Member).
Fineurop Soditic acted as exclusive financial advisor to Sharon Laboratories with a team composed of Gilberto Baj Macario (Senior Partner) and Pietro Maria Rinaldi (Senior Analyst).
Alessandro Giuliani and Nicola Zito of GOP represented Sharon as legal advisors.
RES Pharma Industriale was advised by Walter Pugliese of ProActiva Consulting and the lawyer Alfredo Frangini from FVF Associati.